Gladstone Investment

Recent news

• Rating change
  H.C. Wainwright Maintains Gain Therapeutics(GANX.US) With Buy Rating, Maintains Target Price $8
  Market Newswire · 2026/10/5
• Rating change
  HC Wainwright & Co. Reiterates Buy on Gain Therapeutics, Maintains $8 Price Target
  Benzinga · 2026/10/5
• Rating change
  H.C. Wainwright Reaffirms Their Buy Rating on Gain Therapeutics (GANX)
  TipRanks · 2026/10/5
• Bitcoin, Ether Could Gain If U.S. Rate-Rise Expectations Fall -- Market Talk
  WSJ · 2026/10/6
• Company notice
  Japan Asia Investment: (Update on Disclosure Matters) Notice of Recognition of Extraordinary Gain Following the Subsidiarization of KIC Holdings Co., Ltd.
  JPX · 2026/5/11
• Rating change
  Analysts Offer Insights on Healthcare Companies: Nexalin Technology, Inc. (NXL) and Gain Therapeutics (GANX)
  TipRanks · 2026/10/3
• Rating change
  San Ke Shu (603737): Earnings Fell Short of Expectations; Going Forward, Channel Transformation and New Business Models Will Gain Momentum.
  Shenwan Hongyuan Research · 2026/9/1
• Rating change
  Postal Savings Bank of China (601658) – 2026 H1 Report Commentary: The Second Growth Driver Continues to Gain Momentum, with Non-Interest Income Share Reaching a New High.
  Everbright Securities · 2026/8/29
• Company notice
  C. E. Management Integrated Laboratory: Notice Regarding the Recognition of Extraordinary Losses (Impairment Losses) and Extraordinary Gains (Gain on Sale of Investment Securities)
  JPX · 2026/8/7
• Company notice
  To enable investors to gain a more comprehensive and in-depth understanding of the company's operating performance and financial condition as presented in its 2026 interim report, the company held an earnings briefing on September 4, 2026, from 9:00 a.m. to 10:00 a.m.
  SZSI · 2026/9/7
• Corteva Stock Can Gain 50% After Post-Spin Confusion -- Barrons.com
  Barron's · 2026/10/6
• Rating change
  SuoChen Technology (688507): Revenue posted steady growth in the first half of 2026, with its "Kaiwu" physics‑AI products continuing to gain traction.
  SDIC Securities · 2026/8/31
• Rating change
  BTIG Maintains Gain Therapeutics(GANX.US) With Buy Rating, Maintains Target Price $5
  Market Newswire · 2026/10/5
• Company notice
  Alps Alpine: Notice Regarding Completion of the Sale of Shares of Nippon Seiki Co., Ltd. and Recognition of Gain on Sale of Investment Securities
  JPX · 2026/9/18
• USD/JPY struggles to gain momentum; dollar preference is tempered by intervention concerns, leading to a sluggish pace of appreciation.
  Fisco Japan · 2026/10/5
• SpaceX shares continue to gain momentum, hitting a new high since late June.
  Gelonghui Finance · 2026/10/6
• Rating change
  Midea Group (000333): The B2B segment continues to gain momentum, while overseas OBM is unlocking new growth opportunities.
  Everbright Securities · 2026/9/1
• Company notice
  GIKEN: In Singapore, the market for driving H‑shaped steel sheet piles is expanding, drawing attention in urban development as the advantages of the construction method and the steel material continue to gain widespread acceptance.
  JPX · 2026/7/3
• Rating change
  Maxim Group Maintains Gain Therapeutics(GANX.US) With Buy Rating, Maintains Target Price $7
  Market Newswire · 2026/10/3
• U.S. Natural Gas Futures Gain Ahead of Storage Data -- Market Talk
  WSJ · 2026/10/8

Headlines are aggregated automatically and are not independently verified or edited by our team.